Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to ...

Eli Lilly, the pharma giant behind the popular weight-loss drug Zepbound, said it plans to test obesity medications as a ...

Conagra Brands said the move is a response to the increasing use of GLP-1 medication in the US. Without citing the source of the data, the Hunt’s ketchup maker said the drugs are used by nearly 15 ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

That, according to the firm, make them particularly suitable for users of GLP-1 medications. GLP-1 drugs such as Ozempic and ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Whoopi Goldberg strongly disagreed with Robert F. Kennedy Jr. 's recent criticism of weight loss drugs like Ozempic and Mounjaro, defending both her own and others' use of the medication on The View.

At Institute for Healthcare Improvement meeting, Parkview Health’s Jeffrey Boord, M.D., M.P.H., explained why enhanced ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Eli Lilly ( LLY -1.72%) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its ...